Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1994 Nov;113(3):711–716. doi: 10.1111/j.1476-5381.1994.tb17051.x

Antagonistic properties of McNeil-A-343 at 5-HT4 and 5-HT3 receptors.

A Sagrada 1, G B Schiavi 1, E Cereda 1, H Ladinsky 1
PMCID: PMC1510439  PMID: 7532081

Abstract

1. This study describes the in vitro interaction of the muscarinic ligand McNeil-A-343 with two 5-hydroxytryptamine (5-HT) receptor subtypes, the 5-HT4 and 5-HT3 receptors, using functional as well as radioligand binding studies. 2. In the rat oesophageal muscularis mucosae, precontracted with carbachol, McNeil-A-343 was a competitive antagonist (pA2 6.2) of the 5-HT4 receptor which mediates the relaxation induced by 5-HT. The compound per se relaxed the oesophagus at high concentration only (> or = 10 microM), an effect unchanged by desensitization of the 5-HT4 receptor with 10 microM 5-methoxytryptamine. In the same preparation in the absence of tone, McNeil-A-343 displaced the carbachol concentration-response curve to the right, yielding an apparent affinity (pA2) of 4.9 for muscarinic receptors. 3. In the rat isolated superior cervical ganglion preparation, after blockade of muscarinic and nicotinic receptors, McNeil-A-343 caused a concentration-dependent depolarization that was unaffected by 100 nM ondansetron. The concentration-fast depolarization curve to 5-HT, mediated by the 5-HT3 receptor, was displaced to the right by McNeil-A-343, which showed an apparent affinity (pA2) of 4.8 for the 5-HT3 subtype. 4. In binding studies, McNeil-A-343 recognized a single population of 5-HT4 receptors in pig caudate nucleus, with a pKI of 5.9. The binding affinity of McNeil-A-343 for 5-HT3 receptors in NG 108-15 cells was approximately four times lower (pKI 5.3). Binding affinities (pKI) for muscarinic receptor subtypes in rat tissues were 5.3 (M1, cortex), 5.2 (M2, heart) and 4.9 (M3, submandibular glands), respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
711

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Allen G. S., Rand M. J., Story D. F. Effects of McN-A-343 and DMPP on the uptake and release of 3 H-noradrenaline by guinea-pig atria. Br J Pharmacol. 1972 Jul;45(3):480–489. doi: 10.1111/j.1476-5381.1972.tb08105.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Azami J., Fozard J. R., Round A. A., Wallis D. I. The depolarizing action of 5-hydroxytryptamine on rabbit vagal primary afferent and sympathetic neurones and its selective blockade by MDL 72222. Naunyn Schmiedebergs Arch Pharmacol. 1985 Feb;328(4):423–429. doi: 10.1007/BF00692911. [DOI] [PubMed] [Google Scholar]
  4. Baxter G. S., Clarke D. E. Benzimidazolone derivatives act as 5-HT4 receptor ligands in rat oesophagus. Eur J Pharmacol. 1992 Mar 3;212(2-3):225–229. doi: 10.1016/0014-2999(92)90333-y. [DOI] [PubMed] [Google Scholar]
  5. Baxter G. S., Craig D. A., Clarke D. E. 5-Hydroxytryptamine4 receptors mediate relaxation of the rat oesophageal tunica muscularis mucosae. Naunyn Schmiedebergs Arch Pharmacol. 1991 May;343(5):439–446. doi: 10.1007/BF00169544. [DOI] [PubMed] [Google Scholar]
  6. Bockaert J., Fozard J. R., Dumuis A., Clarke D. E. The 5-HT4 receptor: a place in the sun. Trends Pharmacol Sci. 1992 Apr;13(4):141–145. doi: 10.1016/0165-6147(92)90051-7. [DOI] [PubMed] [Google Scholar]
  7. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  8. Brown D. A., Fatherazi S., Garthwaite J., White R. D. Muscarinic receptors in rat sympathetic ganglia. Br J Pharmacol. 1980 Dec;70(4):577–592. doi: 10.1111/j.1476-5381.1980.tb09777.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Butler A., Elswood C. J., Burridge J., Ireland S. J., Bunce K. T., Kilpatrick G. J., Tyers M. B. The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea-pig tissues. Br J Pharmacol. 1990 Nov;101(3):591–598. doi: 10.1111/j.1476-5381.1990.tb14126.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Butler A., Hill J. M., Ireland S. J., Jordan C. C., Tyers M. B. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors. Br J Pharmacol. 1988 Jun;94(2):397–412. doi: 10.1111/j.1476-5381.1988.tb11542.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cheng Y., Prusoff W. H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973 Dec 1;22(23):3099–3108. doi: 10.1016/0006-2952(73)90196-2. [DOI] [PubMed] [Google Scholar]
  12. Costall B., Naylor R. J., Tuladhar B. R. 5-HT4 receptor mediated facilitation of the emptying phase of the peristaltic reflex in the guinea-pig isolated ileum. Br J Pharmacol. 1993 Dec;110(4):1572–1578. doi: 10.1111/j.1476-5381.1993.tb14003.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Craig D. A., Clarke D. E. Peristalsis evoked by 5-HT and renzapride: evidence for putative 5-HT4 receptor activation. Br J Pharmacol. 1991 Mar;102(3):563–564. doi: 10.1111/j.1476-5381.1991.tb12211.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dumuis A., Bouhelal R., Sebben M., Cory R., Bockaert J. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol Pharmacol. 1988 Dec;34(6):880–887. [PubMed] [Google Scholar]
  15. Eglen R. M., Kenny B. A., Michel A. D., Whiting R. L. Muscarinic activity of McN-A-343 and its value in muscarinic receptor classification. Br J Pharmacol. 1987 Apr;90(4):693–700. doi: 10.1111/j.1476-5381.1987.tb11222.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Eglen R. M., Whiting R. L. Muscarinic receptor subtypes: a critique of the current classification and a proposal for a working nomenclature. J Auton Pharmacol. 1986 Dec;6(4):323–346. doi: 10.1111/j.1474-8673.1986.tb00661.x. [DOI] [PubMed] [Google Scholar]
  17. Eltze M. Muscarinic M1- and M2-receptors mediating opposite effects on neuromuscular transmission in rabbit vas deferens. Eur J Pharmacol. 1988 Jul 7;151(2):205–221. doi: 10.1016/0014-2999(88)90801-1. [DOI] [PubMed] [Google Scholar]
  18. Fox J. E., Daniel E. E., Jury J., Robotham H. Muscarinic inhibition of canine small intestinal motility in vivo. Am J Physiol. 1985 May;248(5 Pt 1):G526–G531. doi: 10.1152/ajpgi.1985.248.5.G526. [DOI] [PubMed] [Google Scholar]
  19. Gale J. D., Grossman C. J., Whitehead J. W., Oxford A. W., Bunce K. T., Humphrey P. P. GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor. Br J Pharmacol. 1994 Jan;111(1):332–338. doi: 10.1111/j.1476-5381.1994.tb14064.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Goyal R. K., Rattan S. Neurohumoral, hormonal, and drug receptors for the lower esophageal sphincter. Gastroenterology. 1978 Mar;74(3):598–619. [PubMed] [Google Scholar]
  21. Grossman C. J., Kilpatrick G. J., Bunce K. T. Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain. Br J Pharmacol. 1993 Jul;109(3):618–624. doi: 10.1111/j.1476-5381.1993.tb13617.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hammer R., Giachetti A. Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. Life Sci. 1982 Dec 27;31(26):2991–2998. doi: 10.1016/0024-3205(82)90066-2. [DOI] [PubMed] [Google Scholar]
  23. Hammer R., Giraldo E., Schiavi G. B., Monferini E., Ladinsky H. Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the rat. Life Sci. 1986 May 5;38(18):1653–1662. doi: 10.1016/0024-3205(86)90409-1. [DOI] [PubMed] [Google Scholar]
  24. Hoyer D., Neijt H. C. Identification of serotonin 5-HT3 recognition sites by radioligand binding in NG108-15 neuroblastoma-glioma cells. Eur J Pharmacol. 1987 Nov 10;143(2):291–292. doi: 10.1016/0014-2999(87)90547-4. [DOI] [PubMed] [Google Scholar]
  25. Ireland S. J., Straughan D. W., Tyers M. B. Influence of 5-hydroxytryptamine uptake on the apparent 5-hydroxytryptamine antagonist potency of metoclopramide in the rat isolated superior cervical ganglion. Br J Pharmacol. 1987 Jan;90(1):151–160. doi: 10.1111/j.1476-5381.1987.tb16835.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Jaramillo J., Volle R. L. Nonmuscarinic stimulation and block of a sympathetic ganglion by 4-(m-chlorophenylcarbamoyloxy)-2-butynyltrimethylammonium chloride (McN-A-343). J Pharmacol Exp Ther. 1967 Aug;157(2):337–345. [PubMed] [Google Scholar]
  27. Kilpatrick G. J., Jones B. J., Tyers M. B. Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature. 1987 Dec 24;330(6150):746–748. doi: 10.1038/330746a0. [DOI] [PubMed] [Google Scholar]
  28. Micheletti R., Schiavone A. Functional determination of McN-A-343 affinity for M1 muscarinic receptors. J Pharmacol Exp Ther. 1990 Apr;253(1):310–314. [PubMed] [Google Scholar]
  29. Newberry N. R., Cheshire S. H., Gilbert M. J. Evidence that the 5-HT3 receptors of the rat, mouse and guinea-pig superior cervical ganglion may be different. Br J Pharmacol. 1991 Mar;102(3):615–620. doi: 10.1111/j.1476-5381.1991.tb12221.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Newberry N. R., Gilbert M. J. 5-Hydroxytryptamine evokes three distinct responses on the rat superior cervical ganglion in vitro. Eur J Pharmacol. 1989 Mar 21;162(2):197–205. doi: 10.1016/0014-2999(89)90282-3. [DOI] [PubMed] [Google Scholar]
  31. Newberry N. R., Priestley T. Pharmacological differences between two muscarinic responses of the rat superior cervical ganglion in vitro. Br J Pharmacol. 1987 Dec;92(4):817–826. doi: 10.1111/j.1476-5381.1987.tb11386.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Parker R. B., Waud D. R. Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists. J Pharmacol Exp Ther. 1971 Apr;177(1):1–12. [PubMed] [Google Scholar]
  33. ROSZKOWSKI A. P. An unusual type of sympathetic ganglionic stimulant. J Pharmacol Exp Ther. 1961 May;132:156–170. [PubMed] [Google Scholar]
  34. Rizzi C. A., Sagrada A., Schiavone A., Schiantarelli P., Cesana R., Schiavi G. B., Ladinsky H., Donetti A. Gastroprokinetic properties of the benzimidazolone derivative BIMU 1, an agonist at 5-hydroxytryptamine4 and antagonist at 5-hydroxytryptamine3 receptors. Naunyn Schmiedebergs Arch Pharmacol. 1994 Apr;349(4):338–345. doi: 10.1007/BF00170878. [DOI] [PubMed] [Google Scholar]
  35. Sagrada A., Duranti P., Giudici L., Schiavone A. Himbacine discriminates between putative muscarinic M1 receptor-mediated responses. Life Sci. 1994;54(17):PL305–PL310. doi: 10.1016/0024-3205(94)00861-2. [DOI] [PubMed] [Google Scholar]
  36. Schiavi G. B., Brunet S., Rizzi C. A., Ladinsky H. Identification of serotonin 5-HT4 recognition sites in the porcine caudate nucleus by radioligand binding. Neuropharmacology. 1994 Mar-Apr;33(3-4):543–549. doi: 10.1016/0028-3908(94)90085-x. [DOI] [PubMed] [Google Scholar]
  37. Waikar M. V., Hegde S. S., Ford A. P., Clarke D. E. Pharmacological analyses of endo-6-methoxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-2,3-dihydro-2-oxo-1 H- benzimidazole-1-carboxylate hydrochloride (DAU 6285) at the 5-hydroxytryptamine4 receptor in the tunica muscularis mucosae of rat esophagus and ileum of guinea pig: role of endogenous 5-hydroxytryptamine. J Pharmacol Exp Ther. 1993 Feb;264(2):654–661. [PubMed] [Google Scholar]
  38. Wakade A. R., Kahn R., Malhotra R. K., Wakade C. G., Wakade T. D. McN-A-343, a specific agonist of M1-muscarinic receptors, exerts antinicotinic and antimuscarinic effects in the rat adrenal medulla. Life Sci. 1986 Dec 1;39(22):2073–2080. doi: 10.1016/0024-3205(86)90358-9. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES